000 | 01940 a2200505 4500 | ||
---|---|---|---|
005 | 20250516171714.0 | ||
264 | 0 | _c20141128 | |
008 | 201411s 0 0 eng d | ||
022 | _a1530-0285 | ||
024 | 7 |
_a10.1038/modpathol.2013.153 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFeeley, Linda P | |
245 | 0 | 0 |
_aDistinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information. _h[electronic resource] |
260 |
_bModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc _cApr 2014 |
||
300 |
_a554-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aBreast Neoplasms _xchemistry |
650 | 0 | 4 |
_aCarcinoma _xchemistry |
650 | 0 | 4 | _aChi-Square Distribution |
650 | 0 | 4 | _aDiagnosis, Differential |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 |
_aKi-67 Antigen _xanalysis |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 | _aNeoplasm Invasiveness |
650 | 0 | 4 | _aOntario |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aReceptor, ErbB-2 _xanalysis |
650 | 0 | 4 |
_aReceptors, Estrogen _xanalysis |
650 | 0 | 4 |
_aReceptors, Progesterone _xanalysis |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xanalysis |
700 | 1 | _aMulligan, Anna M | |
700 | 1 | _aPinnaduwage, Dushanthi | |
700 | 1 | _aBull, Shelley B | |
700 | 1 | _aAndrulis, Irene L | |
773 | 0 |
_tModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc _gvol. 27 _gno. 4 _gp. 554-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/modpathol.2013.153 _zAvailable from publisher's website |
999 |
_c23103253 _d23103253 |